The Biotech Trader Handbook (2nd Edition): A Fast, Simplified & Efficient Guide to Potentially Generate Outsized Returns in Biotech Using Options (for (Paperback) - Common

Small cap biotech companies spend hundreds of millions of dollars and over ten years moving experimental drug candidates from concept to fully approved drugs. For late stage drug candidates, those in Phase III, positive or negative data can result in either massive gains or devastating declines in the sponsoring company's stock price. This "ultimate catalyst event" provides smart, organized & nimb...

• The Pharmagellan Guide to Biotech Forecasting and Valuation
• New Drugs: An Insider's Guide to the FDA's New Drug Approval Process for Scientists, Investors and Patients
• The Biotech Investor's Bible
• Biotechnology Valuation & Investing: Biotech Valuation & Investing
• Middle-Class Millionaire: From $80K in Debt to $3M in Profits through Catalyst Trading
• The BioTech Primer
• Drugs: From Discovery to Approval
• How to Day Trade for a Living: A Beginners Guide to Trading Tools and Tactics, Money Management, Di
• Mastering the Trade, Second Edition: Proven Techniques for Profiting from Intraday and Swing Trading Setups
• Cracking the Code: Understand and Profit from the Biotech Revolution That Will Transform Our Lives and Generate Fortunes